AH
AdaptHealth Corp.
AHCO · NASDAQ
$5.64 +0.80% (+$0.04)
1M -2.59%
Market Cap $757.8M
P/E Ratio -
Div. Yield -
ROE 15.16%
Bulios Fair Price
$4.75
15.8% downside
Current Price
$5.64
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AHCO is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
92 /100
Cheap EV/EBITDA 9.58x
P/S 0.25x
P/B 0.55x
Growth
27 /100
Declining Rev. growth 2.99%
Book val. growth 10.96%
EPS growth N/A
Profitability
9 /100
Weak Gross margin 10.37%
Net margin 7.58%
Op. margin 0.31%
Quality
9 /100
Poor ROIC 0.24%
ROE 15.16%
ROA 5.26%
Debt
17 /100
High Debt/Equity 1.50x
Current ratio 1.12x
Int. coverage -1.41x
Stability
41 /100
Moderate Beta 1.39x
Rev. volatility 4.23%
EPS volatility 666.32%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AHCO
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Suzanne Foster
Employees
10,900
Headquarters
Conshohocken
Upcoming events
03 NOV
Earnings
Upcoming earnings report